Answers are grounded in this paper and cite their sources.
Objective: Rheumatoid arthritis (RA) is an inflammatory condition that causes persistent inflammation by deteriorating the quality and function of the synovium.Prior clinical studies on stem cell transplantation demonstrated promising anti-inflammatory, immunomodulatory, and regenerative benefit for RA.The goal of this study is to assess the efficacy and safety of stem cell transplantation for the management of RA.Methods: Literature searching was conducted using PubMed, EMBASE, Scopus, Cochrane, ProQuest and EBSCOHost databases, including papers evaluating the efficacy of stem cells on RA.Risk of Bias in Non-Randomized Studies -of Interventions (ROB-INS-I) was used to analyze clinical trials and the Cochrane Risk of Bias tool was used for randomized controlled trials (RCTs).Results: This meta-analysis includes 7 RCTs and 12 non-randomized clinical trials involving 682 individuals.Stem cell transplantation was associated with improved efficacy outcomes based on significant improvements in the 1, 3, 6, and 12 months of Disease Activity Score-28 (DAS28); 1 and 3 months of erythrocyte sedimentation rate; 6 and 12 months of C-reactive protein.The most often reported side effects were fever, flu-like symptoms, nausea, and vomiting.Nonetheless, this meta-analysis found a moderate risk of bias with high heterogeneity in all included studies.Conclusion: Stem cell transplantation offers clinical advantages for RA patients with acceptable safety measures.
No takes yet. Share an insight, caveat, or question.
Ferdinand et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: